Concord Biotech Ltd.
CONCORDBIO Share PricePharmaceuticals & Drugs
₹1,610.8
-46.9 (-2.8%)
As on September 8, 2025
Exchange Scrips: BSE543960NSECONCORDBIOISININE338H01029
Market Cap ₹ 16,894 Cr
P/E Ratio 45.34
Dividend Yield 0.66 %
Performance
Market performance
Open1,670
High1,678.3
Volumes48,893
Prev1,610.8
Low1,603.6
As on2025-09-08
Historical performance
1 Year High2,664
3 Year High2,664
5 Year High2,664
1 Year Low1,345
3 Year Low900.05
5 Year Low900.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
16,894
Face Value (₹)
1
P/E Ratio
45.34
Dividend Yield
0.66 %
Investment Returns
1 Year
-12.3%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,664.94 | Bearish |
| 10-DMA | 1,681.27 | Bearish |
| 20-DMA | 1,671.61 | Bearish |
| 50-DMA | 1,754.68 | Bearish |
| 100-DMA | 1,730.94 | Bearish |
| 200-DMA | 1,847.64 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 82039 | 81213 | 81998 | 84292 | 80731 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 45.34.
- 3Y Stock Price CAGR of the stock is 30.7.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹5513 Million.
- The company generated revenue of ₹12001 Million in the previous financial year.
Concord Biotech Ltd.
1610.8-46.9 (-2.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 868636.8
No. of Shares: 539 (Approx)
Performance:-13.1%
P/L: ₹-131363.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent